Article
Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Oct 2003
Saab Sammy, Chang Albert J, Comulada Scott, Geevarghese Sunil K, Anselmo R Dean M, Durazo Francisco, Han Steven, Farmer Douglas G, Yersiz Hasan, Goldstein Leonard I, Ghobrial R Mark, Busuttil Ronald W
Abstract excerpt
The use of hepatitis B core antibody (HBcAb)- and hepatitis C virus antibody (HCV+) liver grafts for transplantation in selected populations has not affected patient and graft survival. We reexamined the clinical outcomes of using these HBcAb+ and HCV+ grafts at our institution, in addition to studying recipients of combined HBcAb+/HCV+ grafts. We identified 377 patients who underwent transplantation for either...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.